Examining the validity of the drivers of COVID-19 vaccination acceptance scale using Rasch analysis

Expert Rev Vaccines. 2022 Feb;21(2):253-260. doi: 10.1080/14760584.2022.2011227. Epub 2021 Dec 19.

Abstract

Background: To well control the pandemic of COVID-19, herd immunity should be achieved. However, people, especially those with better physical conditions (e.g., young adults), may not accept COVID-19 vaccines. Understanding university students' willingness or reluctance to uptake COVID-19 vaccination is important.

Aim: This study aimed to examine the psychometric properties of the DrVac-COVID19S, an instrument that helps assess motivations/drivers of COVID-19 vaccination uptake among university students.

Research design and methods: Using convenience sampling and cross-sectional design, university students (930 from Taiwan [38.0% males] and 1,244 from Ghana [63.3% males]) completed the DrVac-COVID19S using an online survey (Taiwanese students) or paper-and-pen method (Ghanaian students). Rasch analysis was used to examine the psychometric properties of the DrVac-COVID19S.

Results: All 12 items in the DrVac-COVID19S had a satisfactory fit in the Rasch models (infit MnSq = 0.74 to 1.49; outfit MnSq = 0.72 to 1.42). Moreover, the seven-point Likert scale used in the DrVac-COVID19S demonstrated monotonically increasing in their difficulties, which indicated the ordered category. Additionally, no differential item functioning was displayed in the DrVacCOVID-19S across Taiwanese and Ghanaian students.

Conclusions: The DrVacCOVID-19S has good psychometric features to help healthcare providers assess individuals' (especially university students) motivations or drivers to get the COVID-19 vaccination.

Keywords: COVID-19; Rasch; psychometric testing; vaccination uptake; vaccine hesitancy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19 Vaccines*
  • COVID-19*
  • Cross-Sectional Studies
  • Female
  • Ghana
  • Humans
  • Male
  • SARS-CoV-2
  • Vaccination
  • Young Adult

Substances

  • COVID-19 Vaccines